December 6 & 7th 2022 l New York City
New York Academy of Medicine
Plenary Session:
Today’s Challenges and Opportunities in
Psychedelics and Ibogaine Medicine
Plenary Session:
Global Health Clinical Trial Blockchain and
Current Healthcare Technologies.
Corporate Breakfast Keynote address (Sponsored event)
Exhibition Viewing & 1-1 Corporate Matching and Attendee Networking
Global Psychedelic and Ibogaine GMP manufacturing - Challenging the schedule Product
Exhibition Viewing & 1-1 Corporate Matching and Attendee Networking - Coffee, Tea Break
Advances in Psychedelics scheduled products natural products Development & Raw Material Transfer
Corporate Lunch Keynote address (Sponsored event)
Exhibition Viewing & 1-1 Corporate Matching and Attendee Networking
Psychedelics & Ibogaine Clinical Trial Cases Plan of Action
Plenary Session: The Next Big Steps for Psychedelics & Ibogaine GMP Manufacturing Success
National Institute of Drug Abuse (NIDA)/CU Opioid Use Disorder Prevention center
Conference Day 1 VIRTUAL Working Group and Meeting
VIRTUAL WORKING GROUP: The Next Big Steps for Psychedelics & Ibogaine Treatment Manual for Indications
Conference Day 1 Corporate Matching
Attending Network Cocktail 7-10 pm (Sponsored event)
Post-Conference Site tour to Ibogaine, Cannabis, Psychedelic Companies for Pharma Manufacturing Facilities in US, EU, Canada (Ibogaine ABS for Central Africa and Nicaragua)
REGISTER NOW FOR 1-1 Attendee Networking and Company Visit
Post-Conference Site tour to Big Pharma Manufacturing Manufacturing Facilities
Corporate Breakfast Keynote address (Sponsored event)
Exhibition Viewing & 1-1 Corporate Matching and Attendee Networking
Blockchain for Drug Supply Chain Security for Global Harm Reduction
Exhibition Viewing & 1-1 Corporate Matching and Attendee Networking - Coffee, Tea Break
Investment in Future Healthcare Technologies Clinical Trial Platform Blockchain
Corporate Lunch Keynote address (Sponsored event)
Exhibition Viewing & 1-1 Corporate Matching and Attendee Networking
National Drug Research Product Analytics and Quality Control Diagnostics vs Harm Reduction Technology Panel 3D AI/VR/DB Platforms & Know-Drugs APP
Plenary Session: The Next Big Steps for Psychedelics & Ibogaine GMP Manufacturing Success
Opportunities and Challenges in Regulatory Evaluation Panel
Conference Day 1 VIRTUAL Working Group and Meeting